Combinations of 6-mercaptopurine (NSC-755) and 6-(methylmercapto)purine ribonucleoside (NSC-40774) in therapy of Ehrlich ascites carcinoma.
D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice
D000963:Antimetabolites; D015122:Mercaptopurine